Podcasts · Lung Cancer Considered
Lung Cancer Considered: A New Shot at Progress: Amivantamab Goes SubQ
· 36 min
Episode Lung Cancer Considered: A New Shot at Progress: Amivantamab Goes SubQ
0:00
35:43
The FDA has approved subcutaneous amivantamab. Join host Dr. Narjust Florez and guests, Dr. Natasha Leighl and Dr. Federico Cappuzzo, as they explore the science and convenience factor, as well as what this shift means for patients, clinicians, and oncology practice.
Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.